Updated 07:15 GMT, 18 Nov 2026 SPX 7,340.53 -1.03% NDX 27,001.78 -0.72% VIX 25.46 +11.13% GOLD 3,772.20 -2.38% CL 83.98 -2.36% BTC 64,721.99 -0.26%
NAS100 27,002 −0.72% S&P 7,341 −1.03% GOLD $3,772 −2.38% BTC $64,722 −0.26% VIX 25.46 +11.13% latest tape · as of 07:15 UTC
The Screen · Communication Services · Entertainment

Netflix logoNetflix

NFLX · a US exchange · USD · Market cap $262.6B · 16,000 employees

Netflix, Inc.

PASS · Titan Ethical · score 84.2
59.68 USD

Price as of 17 Nov 2026Daily close, not a live quote

Screened 2026-11-17 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price59.68 USD at the 17 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 17 Nov 2026
  • Our regime readDistribution, as of 16 Nov 2026
  • Ethical screenPasses, score 84.2 out of 100
  • OptionsOpen interest leans to puts (put/call 1.59)
  • Last reviewed17 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $51.30 to $82.41, base estimate $71.66 (screen dated 2026-11-17).

Current read
Distribution ?
Undervalued · screened 2026-11-17
  • Trend Distribution
  • Insiders insiders sold, $1,737,551, latest filing 2026-11-09
  • Positioning political selling, disclosed 2026-10-21
  • Options put/call open interest 1.59, read 2026-11-17
  • Ethical passes the values gate
Price59.68 USD
Fair value71.66
Ethical score84.2/100
Value readUndervaluedas of 17 Nov 2026
Our investment reviews on this name
2026-10-27Read Distribution72.61-17.8% to today ✓Markdown gives way to Distribution
2026-10-14Read Markdown70.30-15.1% to today ✓Distribution gives way to Markdown first Markdown read since July
2026-10-02Read Distribution71.15-16.1% to today ✓Markup gives way to Distribution after an 11% slide in 4 weeks
2026-09-06Read Markup80.14-25.5% to today Distribution gives way to Markup after an 8% rise in 4 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Netflix holds its Distribution at $59.68. Consolidating, no directional conviction, held for 26 days.

As held on the ledger · 2026-11-17
PhaseDistribution · caution
Quantitative stateConsolidating, no directional conviction, held for 26 days
Price at the screen$59.68
Valuation18.48 trailing · 16.96 forward price to earnings
Values screenPASS · score 84.2
Beta1.61
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 26.01% Below 33% Interest-bearing debt is just 26.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.05% Below 33% Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit. Pass
Receivables 19.90% Below 49% Money owed to the company is 19.9% of assets, under the 49% limit. Pass
Revenue purity 0.38% Below 5% Only 0.4% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Netflix clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 26%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when NFLX's ethical verdict changes

Today NFLX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 17 Nov 2026: it trades at roughly a 17% discount to our $71.66 fair value, strong competitive moat, 11.80% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

51.30Conservative71.66Base case82.41Growth case 59.68Price

Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. A 16.7% discount to the base estimate.

The Street's Range
57.00Street low 82.00Street average 126.00Street high 59.68Price

Third-party analyst targets: 43 covering, consensus Buy. The average target sits +37% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $71.66, with a range of $51.30 to $82.41, dated to the 2026-11-17 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it stands out

A 12%-growth business trading at just 17.0x forward earnings, with a strong competitive moat. That is a 17% discount to our $71.66 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 43 analysts rate it Buy with a $82.00 average target, about 37% above the screened price.

The fundamentals · plain-English read
Forward P/E17.0xpriced for continued growth
Trailing P/E18.5xreasonably valued
EPS, trailing3.46
EPS, forward3.77
Revenue growth+11.8%steady growth
Profit margin29.7%healthy profit margins
Return on equity53.5%an exceptional return on shareholder capital
FCF yield9.70%
Debt to equity0.60moderate, manageable leverage
Current ratio1.08adequate liquidity, worth monitoring
Beta1.61much more volatile than the market
Short interest, float0.02%
52-week range61.39 - 116.73
MoatSTRONG
Market cap$262.6B
Employees16,000

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Titan Case Study

Our full written analysis of NFLX: Netflix (NFLX) — Markdown Detected: Sellers Control the Narrative at 82 Dollars → 2026-07-02

Where & How to Trade

NFLX trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-17 Distribution $60.75 -5.0% Entry 20

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter.

2026-11-10 Distribution $63.95 +2.6% Entry 19

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter.

2026-11-03 Distribution $62.34 -14.1% Entry 18

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter. Since the last review it its composite score eased.

2026-10-27 Distribution · changed $72.61 +0.0% Entry 17

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter.

2026-10-20 Markdown $72.61 +0.0% Entry 16

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-19 Markdown $72.61 +0.0% Entry 15

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-18 Markdown $72.61 +0.0% Entry 14

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-17 Markdown $72.61 +0.0% Entry 13

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-16 Markdown $72.61 +2.9% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-15 Markdown $70.57 +0.4% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (44 analysts) rates it buy, with a mean price target of $115. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on NFLX

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in NFLX's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · NFLX
DateInsiderTitleTypeSharesValue
2026-11-09 Peters Gregory K Co-CEO S - Sale 27,312 $1,737,551
2026-11-04 Hyman David A GC S - Sale+OE 5,727 $369,678
2026-10-26 Smith Bradford L Dir S - Sale+OE 17,980 $1,151,193
2026-05-07 Peters Gregory K Co-CEO Sale 27,312 $2,422,421
2026-05-07 Neumann Spencer Adam CFO Sale 9,253 $823,075
2026-05-05 Sarandos Theodore A Co-CEO Sale 27,312 $2,402,627
2026-05-05 Hyman David A GC Sale 5,722 $504,021
2026-05-01 Hastings Reed Dir Sale 407,550 $37,956,938
2026-04-02 Neumann Spencer Adam CFO Sale 28,630 $2,805,740
2026-04-01 Hastings Reed Dir Sale 420,550 $40,156,465

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming NFLX
DatePoliticianPartyTypeAmount
2026-10-21 Ro Khanna Democrat sell 1K–15K
2026-10-21 Ro Khanna Democrat sell 1K–15K
2026-10-21 Ro Khanna Democrat sell 1K–15K
2026-10-07 Ro Khanna Democrat sell 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $85.45 -3.9% · $961 -3.9%
2 months $103.01 -20.3% · $797 -20.3%
3 months $94.31 -12.9% · $871 -12.9%
6 months $94.09 -12.7% · $873 -12.7%
1 year $120.36 -31.8% · $683 -31.8%
2 years $64.45 +27.5% · $1,275 +27.5%
3 years $42.00 +95.6% · $1,956 +95.6%
5 years $48.88 +68.1% · $1,681 +68.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever NFLX does next, these words stay.

Netflix · NFLX · Distribution · $59.68
Recorded 2026-11-17 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.